News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
Top Breaking News
Allergan Inc. (AGN) Rejected Actavis (ACT) Takeover Bid; In Advanced Talks To Buy Salix Pharmaceuticals, Ltd. (SLXP)     9/23/2014
Allergan Inc. (AGN) Ordered To Show Business Strategy Documents     9/23/2014
San Diego-Based Cytori Therapeutics, Inc. (CYTX) Chops Staff, EVP Under Pressure From Lenders     9/22/2014
Regeneron Pharmaceuticals, Inc. (REGN) R&D Chief Reveals Allergy Drug May Be Darling Of Its Pipeline     9/22/2014
Bay Area's Dermira Supersizes IPO Up 30% To $98M     9/22/2014
Merck KGaA (MKGAF.PK) To Pay $17 Billion For St. Louis-Based Sigma-Aldrich Corporation (SIAL)     9/22/2014
Auxilium Pharmaceuticals (AUXL) Rejects $2.2B Bid From Endo International plc (ENDP), While QLT Inc. (QLTI) Merger Looks More Likely     9/22/2014
Avalon Ventures, GlaxoSmithKline (GSK) Bet $20M On Two Biotech Startups     9/22/2014
University of California, San Francisco (UCSF), University of California, Santa Cruz (UCSC) Spinoff Circle Scores Seed Funding From QB3’s VC Fund, Pfizer (PFE)     9/22/2014
GlaxoSmithKline (GSK) Deals With Fallout From Polio Virus Spill     9/22/2014
Fate Of Massive Ex-Pfizer (PFE) HQ In Morris Plains Remains In Limbo     9/22/2014
FDA Chides Cipher Pharmaceuticals (DND.TO) Over Cholesterol Drug Ad's Superiority Claims     9/22/2014
San Diego's TRACON Pharmaceuticals, Inc. Reels In $27 Million     9/22/2014
Innovus Pharma, Orimed Pharma Ink $94.5 Million+ Zestra® Pact     9/22/2014
Merck KGaA (MKGAF.PK)’s $17B Buy Of Sigma-Aldrich Corporation (SIAL) A Smart Deal: Analysts     9/22/2014

Featured Stories
Biotech Layoffs Often Go Hand-In-Hand With CEO Pay Raises     9/22/2014
3 Reasons Why Healthcare Will Favor Google Inc. Over Apple (AAPL)     9/22/2014
GlaxoSmithKline (GSK)'s Hefty Fine Signals No Immunity For Multinationals     9/22/2014
California Institute of Technology Scientists Use Light To Make Mice Asocial     9/22/2014
Working Together Boosts Motivation, Stanford University Research Shows     9/22/2014
Wild Berry Extract May Boost Effect Of Pancreatic Cancer Drug, University of Southampton Study     9/22/2014
Exercise Boosts Tumor-Fighting Ability Of Chemotherapy, University of Pennsylvania Team Finds     9/22/2014
New "Evolved" Protein That May Stop Cancer From Spreading, Stanford University Reveals     9/22/2014
Stanford University Scientists Track The Rise And Fall Of Brain Volume Throughout Life     9/22/2014
Top 10 Fastest Growing Employers Outside Of Big Pharma     9/19/2014
Angelina Jolie Surgery Sparks Surge In Female Cancer Tests     9/19/2014
PTSD Link To Food Addiction, University of Minnesota Study     9/19/2014
World Population To Keep Growing This Century, Hit 11 Billion By 2100, University of Washington Study     9/19/2014
The Science Of How Diet Sodas Are Making You Fat , Weizmann Institute of Science Study     9/19/2014
Can One Dose Of Antidepressant Lead To Changes In Your Brain? Max Planck Institute For Human Cognitive And Brain Sciences Study     9/19/2014

More News
Mylan Pharmaceuticals, Inc. (MYL) Recalls Nitroglycerin Spray Due To Defective Pump     9/22/2014
Regeneron Pharmaceuticals, Inc. (REGN) Announces EYLEA® (aflibercept) Injection Approved For The Treatment Of Patients With Myopic Choroidal Neovascularization (CNV) In Japan     9/22/2014
Amgen (AMGN) Submits Biologics License Application For Investigational BiTE® Immunotherapy Blinatumomab     9/22/2014
Minerva Neurosciences, Inc. (NERV) Announces Completion Of FDA Review Of Investigational New Drug Application For MIN-202 And Plans For First U.S.-Based Clinical Trial     9/22/2014
TauRx Therapeutics Achieves Enrollment Target For Second Phase 3 Clinical Trial Of LMTX™ In Alzheimer's Disease     9/22/2014
Threshold Pharmaceuticals, Inc. (THLD) Announces Its Phase 3 Trial Of TH-302 In Patients With Advanced Soft Tissue Sarcoma Will Continue As Planned Following Protocol-Specified Interim Analysis     9/22/2014
Dynavax Technologies Corporation (DVAX) Completes Enrollment Of Phase 3 Study Of HEPLISAV-B™     9/22/2014
Alcobra (ADHD) Announces Completion Of All Patient Visits In Phase 3 Clinical Trial Of MDX In Adult ADHD     9/22/2014
Tenax Therapeutics Announces First Patients Enrolled In Phase 3 LEVO-CTS Clinical Trial Of Levosimendan     9/22/2014
Elusys Therapeutics, Inc. Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program     9/22/2014
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS – Phase II Trial Results Published In The Leading Medical Journal Neurology     9/22/2014
Bio Blast Pharma Announces Initiation Of Its Canadian OPMD Clinical Study Center At McGill University, Montreal     9/22/2014
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS - Phase II Trial Results Published In The Leading Medical Journal Neurology     9/22/2014
Progenics Pharmaceuticals, Inc. (PGNX) Presents Long Term Follow-Up Of Pivotal Phase 2 Trial Of Azedra In Malignant Pheochromocytoma     9/22/2014
FibroGen, Inc.Announces One-Year Data Supporting The Safety And Efficacy Profile Of FG-3019 In Patients With Idiopathic Pulmonary Fibrosis     9/22/2014
DBV Technologies Announces Primary Endpoint Met In VIPES, Viaskin Peanut's Phase 2b Clinical Trial In Peanut Allergy     9/22/2014
NeuralStem Inc. ALS Investigator Presents Long-Term Follow Up Phase I Data     9/22/2014
Promedior Announces Presentation Of Retrospective Quantitative Imaging Analysis Of Phase 1b Data In Idiopathic Pulmonary Fibrosis     9/22/2014
Tekmira Pharmaceuticals Corporation (TKMR) Establishes Regulatory Framework For Emergency Use Of TKM-Ebola     9/22/2014
Hemispherx Biopharma (HEB) Announces Primate Research Showing Alferon® LDO Protection From Pulmonary Damage Associated With Infection By Highly Pathogenic Influenza Virus     9/22/2014
University of California, Irvine Completes Pterostilbene Study For Prevention Of Skin Damage From UV Exposure     9/22/2014
Nuvilex (NVLX)'s Partner, Austrianova, Publishes Scientific Review Article Emphasizing Use Of Cell-In-A-Box® For Treatment Of Diabetes     9/22/2014
Albert Einstein College of Medicine Release: Brainwave Test Could Improve Autism Diagnosis And Classification     9/22/2014
University of California, Davis (UCD) Release: Mothers Of Children With Autism Less Likely To Have Taken Iron Supplements During Pregnancy     9/22/2014
Masimo Corporation (MASI) PVI® Helped Assess Fluid Responsiveness In Clinical Study Of Adult, Noncardiac Patients     9/22/2014
Hemispherx Biopharma (HEB) Announces Primate Research Showing Alferon® LDO Protection From Pulmonary Damage Associated With Infection By Highly Pathogenic Influenza Virus     9/22/2014
Horizon Pharma plc.  (HZNP) Completes Acquisition Of Vidara Therapeutics     9/22/2014
NovaDel Pharma (NVD) Announces The Sale Of Its Zolpimist® New Drug Application, License And Intellectual Property To Amherst Pharmaceuticals, LLC     9/22/2014
Clinical Network Services Pty Ltd (CNS) And Ventac Partners Sign Cooperative Partnership     9/22/2014
Abcam plc (ABC.L) Licenses Novel Ceefourin Inhibitors Of Multidrug Resistance Protein 4 From Australia’s Children’s Cancer Institute     9/22/2014
CSPC Pharmaceutical Group To Support Drug Discovery Work At Columbia University     9/22/2014
MediGene AG (MDGEF.PK): New Research Collaborations And Additional Grant For Immunotherapy TABs     9/22/2014
SCHOTT Corporation And Algatechnologies Join R&D Forces     9/22/2014
Fidia Pharma USA Partners With Aeonsurgical To Expand Its US Sales Presence     9/22/2014
Generex Biotechnology Corporation (GNBT) Collaborates With University Health Network For Buccal Insulin Project     9/22/2014
Boston Therapeutics, Inc. Signs Clinical Trial Agreement With Prestigious Joslin Diabetes Center For Phase III Study Of BTI-320     9/22/2014
Critical Path Institute Receives Second Grant For Advancing Tuberculosis Treatments     9/22/2014
Helsinn To Provide Independent Educational Grant Support For A Satellite Symposium On Delivering Chemotherapy With Confidence: New Strategies To Minimize Treatment-Induced Nausea And Vomiting At The 38th European Society For Medical Oncology (ESMO) Congress     9/22/2014
Bristol-Myers Squibb Company (BMY) And Pfizer (PFE) Announce Charitable Donations Of More Than $1 Million To Support Cardiovascular Education For Patients And Caregivers     9/22/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union     9/22/2014
Telormedix Granted European Patent For Vesimune     9/22/2014
Lannett Company, Inc. (LCI) Launches Oxycodone Hydrochloride Oral Solution     9/22/2014
Spherix (SPEX) Notified By United States Patent & Trademark Office Of New Standard Essential Patent Issued To Spherix     9/22/2014
Inovio Pharmaceuticals (INO) Expands HPV Immunotherapy Development To Aerodigestive Cancers     9/22/2014
Parenteral Drug Association Launches Effort To Harmonize Global Post-Approval Changes Protocols     9/22/2014
Transition Therapeutics Inc. (TTH.TO) To Hold Conference Call On Full Year Fiscal 2014 Financial Results On Thursday, September 25th, At 4:30 P.M. EST     9/22/2014
Xstelos Announces Intention To Vote Against Affymax, Inc. (AFFY)'s Plan Of Liquidation At September 23, 2014 Special Meeting of Shareholders     9/22/2014
Xenetic Biosciences To Hold Business Update Conference Call September 23 At 6:00 A.M. Eastern Time     9/22/2014
Skyepharma PLC (SKYEF) Announces Notice Of Early Repayment Of Euro CRC Facility     9/22/2014
SYGNIS’ New TthPrimPol Polymerase Took Centre Stage At Zing DNA Polymerases Conference 2014     9/22/2014
PREMIER Biosoft International Delivers Version 2.0 Of OligoEvaluator™ To Sigma(R) Life Science     9/22/2014
Bio-Rad Laboratories, Inc. (BIO)'s New ChemiDoc™Touch Imaging System Surpasses Film’s Performance, Simplifies Western Blot Detection     9/22/2014
Nordic Nanovector: Registered Share Capital Increase     9/22/2014
Dyax Corp. (DYAX) Highlights Recent Progress In Licensing And Funded Research Portfolio     9/22/2014
Swedish Orphan Biovitrum Opens North American Operations     9/22/2014
Allergy Therapeutics plc Preliminary Results For The Year Ended 30 June 2014     9/22/2014
AbbVie (ABBV) Declares Quarterly Dividend     9/22/2014
Neogen Corporation (NEOG) Reports 13% Net Income increase     9/22/2014
Synageva BioPharma (GEVA) Appoints Robert Bazemore As Chief Operating Officer     9/22/2014
Celladon Corporation Appoints Scott Garrett Vice President, Commercial Planning     9/22/2014
ChemoCentryx, Inc. (CCXI) Appoints Israel F. Charo, M.D., Ph.D., Senior Vice President Of Research     9/22/2014
RainDance Technologies Names Fritz Eibel As Senior Vice President Of Strategic Marketing     9/22/2014
Cerebain Biotech Engages Miriam Weber Miller, Industry Veteran, As Corporate Vice President     9/22/2014
Codexis, Inc. (CDXS) Appoints Biotechnology Industry Veteran, Kathleen Glaub, To Board Of Directors     9/22/2014
Domain Therapeutics Appoints Professor Michel Bouvier As Chairman Of The Scientific Advisory Board     9/22/2014
Nanobiotix Expands Operations Into The U.S.A. As Part Of Its International Development Strategy     9/22/2014
Provectus Biopharmaceuticals Inc. Appoints Christopher Kaplan To Its Strategic Advisory Board     9/22/2014
Premier Biomedical Announces The Addition Of K. Adam Dubov, Esq. To Scientific Advisory Board     9/22/2014
SRA International, Inc. (SRX) Recognized As Healthiest Employer Of Greater Washington     9/22/2014
Society For Clinical Research Sites' Good Clinical Practice Training Recognized By TransCelerate BioPharma     9/22/2014
Bio-Process Systems Alliance Releases 2014 Particulates Guide     9/22/2014
Shire’s Big Give Seeks Books And Other Much-Needed Donations To Help Children In Need     9/22/2014
Cellceutix (CTIX) To President Obama: We Have The Tools And Will Rise Up To The Challenge To Prevent Antibiotic Resistant Bacteria Becoming A Serious Threat To Public Health     9/22/2014
Endo International plc (ENDP) Comments On Auxilium Pharmaceuticals (AUXL)' Rejection Of Its Acquisition Proposal     9/22/2014
Zynx Health Unveils Revolutionary Evidence-Based Mobile Care Team Coordination And Secure Messaging Solution     9/22/2014
Association of Clinical Research Organizations (ACRO) Release: House Resolution Champions Clinical Research Innovation     9/22/2014
Brain & Behavior Research Foundation Awards 200 NARSAD Young Investigator Grants Valued Over $12.7 Million to Scientists Pursuing Innovative Mental Health Research     9/22/2014
PREMIER Biosoft International Release: Arun Apte Honored As Bronze Winner At The 6th Annual 2014 Golden Bridge Awards For CEO/Executive Of The Year     9/22/2014
PHT Corporation Patient Connect ™ Engagement App Is A Finalist For SCDM Technology Innovation Award; VP Of Marketing/Corporate Strategy Sheila Rocchio To Lead Session On BYOD & Future Trends For Ecoa     9/22/2014
Onxeo Attends InvestorDagen 2014, The Largest Danish Private Investor Event     9/22/2014
AbbVie (ABBV) To Present Clinical Study Data On Potential New Oncology Medicines At The 2014 European Society Of Medical Oncology Annual Meeting     9/22/2014
CytRx Corporation (CYTR) Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas And Global Phase 2b Small Cell Lung Cancer Trial Designs At ESMO 2014 Congress     9/22/2014
ContraFect Corporation (CFRXU) To Present At BioCentury's 21st Annual NewsMakers In The Biotech Industry Conference     9/22/2014
TxCell To Participate At Société Générale Healthcare & Biotechnology Conference, Paris     9/22/2014
Kibow Biotech, Inc. Presents Renadyl Story About Kidney Function At Harvard Medical School Probiotics Symposium     9/22/2014
Systech To Host Serialization Webinar For The Pharmaceutical Industry     9/22/2014
EPIRUS Biopharmaceuticals To Present At NewsMakers In The Biotech Industry Conference     9/22/2014
Agile Therapeutics, Inc. To Present At The 21st Annual Biocentury Newsmakers Conference     9/22/2014
Arrowhead Research Corporation (ARWR) To Present At Biocentury’s NewsMakers In The Biotech Industry Conference     9/22/2014
Arena Pharmaceuticals, Inc. (ARNA) To Present At The NewsMakers In The Biotech Industry Conference     9/22/2014
GlycoMimetics, Inc. (GLYC) To Present At Biocentury's 21st Annual Newsmakers In The Biotech Industry Conference     9/22/2014
Repros Therapeutics Inc. (RPRX) Gives Update On Androxal® With Respect To Recent FDA Advisory Panel Outcome And Announces Upcoming Presentation At Biocentury     9/22/2014
Week In Review: GlaxoSmithKline (GSK) Ends China Bribery Investigation By Paying $489 Million Fine     9/22/2014

Career Tips
How Biotechs Are Focusing On Employee Retention     9/22/2014
Pfizer (PFE) And Merck & Co. (MRK) Execs Exclusive: Inside Tips For Getting Hired     9/18/2014
6 Job Interview Blunders To Avoid     9/11/2014
What You MUST Ask Before You Leave The Interview     9/11/2014
Repairing Your Cover Letter And Resume After Getting Fired     9/11/2014
10 Types Of Positive And Negative Networkers     9/11/2014
How To Craft An Attention-Getting Resume     9/11/2014
Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc. (ARNA)     8/26/2014
Best Biotech Employers In America     8/26/2014
4 Untrue Things Biotech Employers May Tell Candidates     8/21/2014
Top 31 Common Interview Questions And Answers     8/21/2014
6 Tips To Ace Your Next Phone Interview     8/21/2014
How NOT To Write Your Resume     8/21/2014
Cover Letters For The Overqualified: How To Get Your Foot In The Door     8/21/2014
7 Reasons Why Recruiters And Employers Dread Reading A Resume     8/21/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do

Press Release Submissions
Post your news